221 related articles for article (PubMed ID: 6977624)
21. Quantitative cerebral blood flow measurements using N-isopropyl-(iodine 123) p-iodoamphetamine and single photon emission computed tomography with rotating gamma camera.
Matsuda H; Seki H; Sumiya H; Tsuji S; Tonami N; Hisada K; Fujii H; Kobayashi H
Am J Physiol Imaging; 1986; 1(4):186-94. PubMed ID: 3502526
[TBL] [Abstract][Full Text] [Related]
22. Cerebral abnormalities in cocaine abusers: demonstration by SPECT perfusion brain scintigraphy. Work in progress.
Tumeh SS; Nagel JS; English RJ; Moore M; Holman BL
Radiology; 1990 Sep; 176(3):821-4. PubMed ID: 2389042
[TBL] [Abstract][Full Text] [Related]
23. [N-isopropyl-p-[I123] iodoamphetamine single photon emission computed tomography (I123-IMP SPECT) and child neurology].
Tada H; Morooka K; Arimoto K; Matsuo T; Takagi K; Yanagawa E
No To Hattatsu; 1992 Sep; 24(5):462-8. PubMed ID: 1389330
[TBL] [Abstract][Full Text] [Related]
24. Cerebral dynamics of N-isopropyl-(123I)p-iodoamphetamine.
Creutzig H; Schober O; Gielow P; Friedrich R; Becker H; Dietz H; Hundeshagen H
J Nucl Med; 1986 Feb; 27(2):178-83. PubMed ID: 3486950
[TBL] [Abstract][Full Text] [Related]
25. Functional mapping of flow and back-diffusion rate of N-isopropyl-p-iodoamphetamine in human brain.
Yonekura Y; Nishizawa S; Mukai T; Iwasaki Y; Fukuyama H; Ishikawa M; Tamaki N; Konishil J
J Nucl Med; 1993 May; 34(5):839-44. PubMed ID: 8478721
[TBL] [Abstract][Full Text] [Related]
26. [Cerebral blood flow studies using N-isopropyl I-123 p-iodoamphetamine in cerebral ischemic lesions].
Kobayashi H; Hayashi M; Kawano H; Handa Y; Kabuto M; Noguchi Y; Shirasaki N; Yamamoto S; Matsuda H
No To Shinkei; 1986 Jan; 38(1):75-80. PubMed ID: 3485981
[TBL] [Abstract][Full Text] [Related]
27. [Semi-quantitative method of N-isopropyl-(123I)-p-iodoamphetamine accumulation in cerebrum: cerebrum to cerebellum accumulation ratio].
Tomimoto H; Hayashi M; Kawahara Y; Kiyokawa F; Fukunaga M
Radioisotopes; 1987 Dec; 36(12):650-2. PubMed ID: 3502292
[TBL] [Abstract][Full Text] [Related]
28. Correlation of abnormalities of interictal n-isopropyl-p-iodoamphetamine single-photon emission tomography with focus of seizure onset in complex partial seizure disorders.
Dietrich ME; Bergen D; Smith MC; Fariello R; Ali A
Epilepsia; 1991; 32(2):187-94. PubMed ID: 2004622
[TBL] [Abstract][Full Text] [Related]
29. [N-isopropyl-p-[123I]iodoamphetamine early dynamic image with ring-type emission CT in cerebrovascular disease].
Kachi K; Uchiyama G; Koizumi K; Karikomi M; Hihara T; Araki T; Kakizawa T; Nukui H; Fujimoto H
Kaku Igaku; 1989 Mar; 26(3):369-74. PubMed ID: 2787436
[TBL] [Abstract][Full Text] [Related]
30. An assessment of the role of 123I-N-isopropyl-p-iodoamphetamine with single-photon emission computed tomography in the diagnosis of stroke and Alzheimer's disease.
Killen AR; Oster G; Colditz GA
Nucl Med Commun; 1989 Apr; 10(4):271-84. PubMed ID: 2662071
[TBL] [Abstract][Full Text] [Related]
31. [Semiquantitative display of regional cerebral blood flow and neuronal function using N-isopropyl-(123I)-p-iodoamphetamine (IMP) and emission tomography].
Meili A; Bekier A; Weder B
Nuklearmedizin; 1985 Aug; 24(4):153-8. PubMed ID: 3878497
[TBL] [Abstract][Full Text] [Related]
32. [Diagnostic value of high N-isopropyl-p-[123I] iodoamphetamine (IMP) uptake in brain tumors].
Fukahori T; Tahara T; Mihara F; Kato A; Masumoto H; Kudo S; Tsuji T; Tabuchi K
Nihon Igaku Hoshasen Gakkai Zasshi; 1996 Jan; 56(1):53-9. PubMed ID: 8857100
[TBL] [Abstract][Full Text] [Related]
33. Cerebral blood flow studies using N-isopropyl I-123 p-iodoamphetamine.
Kobayashi H; Hayashi M; Kawano H; Handa Y; Nozaki J; Yamamoto S; Matsuda H
Stroke; 1985; 16(2):293-6. PubMed ID: 3871978
[TBL] [Abstract][Full Text] [Related]
34. [Cerebral emission computer tomography (SPECT) with 123I-labeled amphetamines].
Biersack HJ; Penin H; Hartmann A; Reichmann K; Winkler C
Dtsch Med Wochenschr; 1984 Jul; 109(30):1155-9. PubMed ID: 6611249
[TBL] [Abstract][Full Text] [Related]
35. Amines for brain tomoscintigraphy.
Moretti JL; Cinotti L; Cesaro P; Defer G; Joulin Y; Sergent A; Vigneron N; Rapin JR; Raynaud C
Nucl Med Commun; 1987 Jul; 8(7):581-95. PubMed ID: 3500437
[TBL] [Abstract][Full Text] [Related]
36. Cerebral blood-flow tomography: xenon-133 compared with isopropyl-amphetamine-iodine-123: concise communication.
Lassen NA; Henriksen L; Holm S; Barry DI; Paulson OB; Vorstrup S; Rapin J; le Poncin-Lafitte M; Moretti JL; Askienazy S; Raynaud C
J Nucl Med; 1983 Jan; 24(1):17-21. PubMed ID: 6600275
[TBL] [Abstract][Full Text] [Related]
37. [Clinical assessment of cerebral blood flow image using N-isopropyl-p-[123I]iodoamphetamine (IMP) and single photon emission computed tomography (SPECT)].
Shiozaki H; Kishikawa T; Ikeda J; Baba H; Fujii K; Shibasaki H
Kaku Igaku; 1985 Apr; 22(4):449-58. PubMed ID: 3874308
[No Abstract] [Full Text] [Related]
38. Early and delayed SPECT using N-isopropyl p-iodoamphetamine iodine 123 in cerebral ischemia. A prognostic index for clinical recovery.
Defer G; Moretti JL; Cesaro P; Sergent A; Raynaud C; Degos JD
Arch Neurol; 1987 Jul; 44(7):715-8. PubMed ID: 3496075
[TBL] [Abstract][Full Text] [Related]
39. I-123 Iofetamine SPECT scan in children with neurological disorders.
Flamini JR; Konkol RJ; Wells RG; Sty JR
Wis Med J; 1990 Oct; 89(10):584-7. PubMed ID: 2238681
[TBL] [Abstract][Full Text] [Related]
40. [Visualization of epileptic lesions using single photon emission computed tomography (SPECT) with N-isopropyl-p-(123I) iodoamphetamine after intravenous loading of bemegride--report of a case].
Kawamura M; Murase K; Yasuhara Y; Mogami H; Tanada S; Hamamoto K; Hatakeyama T; Kimura H; Sakaki S
Nihon Igaku Hoshasen Gakkai Zasshi; 1989 Feb; 49(2):199-205. PubMed ID: 2787907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
